Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Goldman Sachs Group
(NY:
GS
)
548.45
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Goldman Sachs Group
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
IBM Story Is Underappreciated, Goldman Sachs Says Stock Can Re-Rate Higher
February 05, 2025
Goldman Sachs analyst maintains Buy rating on IBM, citing potential for growth in TMT sector and strong Software revenue outlook.
Via
Benzinga
Uber Stock Tumbles, Analyst Lists Autonomous Vehicles As 'Key Risk'
February 05, 2025
Goldman Sachs analyst maintains Buy rating on Uber Technologies Inc with $96 price target. Q4 gross bookings beat estimates with strong Mobility & Delivery segments. Adjusted EBITDA & EPS in line with...
Via
Benzinga
3 Must-Have ETFs Set to Dominate This Quarter
February 05, 2025
There are three areas in the market that could clearly command a rotation in the coming quarter, backed by economic tailwinds and themes.
Via
MarketBeat
Topics
Bonds
ETFs
Economy
Exposures
Debt Markets
Economy
Interest Rates
Looking At Goldman Sachs Gr's Recent Unusual Options Activity
February 05, 2025
Via
Benzinga
What Drives Billionaire Masayoshi Son?
February 05, 2025
The man behind SoftBank has now teamed up with OpenAI to invest up to $500 billion in American AI infrastructure over the next four years.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Check Out What Whales Are Doing With Goldman Sachs Gr
February 03, 2025
Via
Benzinga
1 Vanguard Index Fund May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst
February 05, 2025
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025
February 04, 2025
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
PepsiCo Remains Very Well Positioned Despite Near-Term Headwinds: Goldman Sachs
February 04, 2025
Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of PepsiCo with a price forecast of $189.00.
Via
Benzinga
Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
February 04, 2025
Goldman Sachs and Morgan Stanley are two of the leading investment bankers on Wall Street posting double digit revenue growth in Q4, but which has more upside?
Via
MarketBeat
The Smartest Vanguard ETF to Buy With $1,000 Right Now
February 04, 2025
Via
The Motley Fool
Topics
ETFs
4 Banks to Buy Ahead of Trump's Deregulatory Blitz
February 03, 2025
Fed keeps rates steady, but uncertainty remains. Banking sector could benefit from deregulation. Consider BAC and GS for favorable metrics.
Via
Benzinga
Topics
Economy
Government
Exposures
Interest Rates
Political
Should You Buy XRP (Ripple) While It Trades Under $3?
February 03, 2025
Via
The Motley Fool
Where Will Nvidia Stock Be in 3 Years?
February 02, 2025
Via
The Motley Fool
3 Reasons to Buy Amazon Stock Like There's No Tomorrow
February 02, 2025
Via
The Motley Fool
Why Brighthouse Financial Stock Blasted Higher This Week
January 31, 2025
Via
The Motley Fool
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
January 31, 2025
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug exposure.
Via
Benzinga
Goldman Sachs Forecasts Limited Upside For Occidental & Magnolia: What's Next?
January 31, 2025
Goldman Sachs downgrades MGY and OXY, reinstates coverage on EXE. MGY's outperformance reflected in current stock price, OXY's leverage a concern. EXE receives Buy rating with potential 18% upside.
Via
Benzinga
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
January 31, 2025
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.
Via
Benzinga
Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs
January 31, 2025
Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.
Via
Benzinga
Will the Stock Market Crash or Soar in 2025? Wall Street Has a Definitive Answer.
January 31, 2025
Via
The Motley Fool
North Face Parent VF Corp's Q3 Marks First Revenue Growth In Nine Quarters, But Goldman Sachs Stays Neutral
January 30, 2025
VF Corp delivered a strong Q3 performance, exceeding expectations, with significant improvements across all regions. Goldman Sachs analyst Brooke Roach reiterated a Neutral rating, raising the price...
Via
Benzinga
Caterpillar Has Potential For Multiple Expansion Post Earnings, Goldman Sachs Says
January 30, 2025
Goldman Sachs analyst Jerry Revich believes Caterpillar's mixed Q4 results may signal a cyclical trough, with potential for multiple expansion.
Via
Benzinga
Billionaire Investor Ray Dalio Backs Trump's Interest Rate Cut, Proposes '3% Solution' To Tackle $36 Trillion America's Debt Crisis
January 30, 2025
Ray Dalio, founder of Bridgewater Associates, called for urgent measures to address the mounting U.S. federal debt crisis during an interview on The All-In Podcast, emphasizing the need to reduce the...
Via
Benzinga
Topics
Government
Exposures
Political
Nvidia Stock Investors Just Got Good News From President Donald Trump and Wall Street
January 30, 2025
Via
The Motley Fool
Topics
Government
Exposures
Political
What's In The Cards For Walmart This Earnings Season?
January 29, 2025
Goldman Sachs reiterates Buy on Walmart with a $101 target, citing strong earnings growth, automation benefits, and upcoming strategic meetings.
Via
Benzinga
Moderna Stock Is Sliding Wednesday: Here's Why
January 29, 2025
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need to know.
Via
Benzinga
Big Banks Hit Fresh Record Highs: Goldman Sachs Sees More Upside In 2025
January 29, 2025
U.S. banks reach record highs on strong Q4 earnings, driven by lending income, cost-cutting, and deal-making. Goldman Sachs predicts continued growth.
Via
Benzinga
DeepSeek Selloff Is A Correction, Not Start Of 'Sustained Bear Market': Goldman Sachs
January 29, 2025
Goldman Sachs sees temporary setback, not bear market. High market concentration poses risk but also opportunity to diversify and stay invested.
Via
Benzinga
3 Trucking Stocks Leading the Way in Market Momentum
January 29, 2025
Three stocks in the transportation sector broke out this week, giving investors what may be the start of a longer-lasting rally.
Via
MarketBeat
Topics
Economy
Government
Exposures
Economy
Political
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.